RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Go to hellI doubt this chart will show up once I hit post but it shows the quarterly sales trend for Egrifta and it is looking pretty sweet. I am glad they didn't give up on it as it is helping right now. I am not sure if they can keep it going but the trend is your friend with THTX's most profitable drug.
The prospects for TH-1902 and the Sort1+platform are still what really matters as well as getting off a decent financing, but Egrifta is helping on the margin. If TH-1902 looks good, all should be easy on the financing front. If not, we will be glad we still have Egrifta.
Trogarzon wrote: Don't know why but the first time 8 met Huss he discarded egrifta as a sidekick and wanted go after the statins instead with the coumpound or somthing like that. Anyway he never had a chance to destroy the whole company like Paul is trying to with his ideas of grandeur. Just the way he was commenting on the 500m market cap at the time.. like oh that thing like it did not matter... now that it's halved again he still doe'nt see it for what it is.. the only thing that matters to us shareholders... he's on a different quest than us my friends..